As personalized medicine evolves, the chromosomal microarray market is poised for continued innovation and broader clinical application.

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Neurological Disorders, Advanced Sequencing ...

EPperPRINT, a global leader in peptide microarray technology, celebrates its 15th anniversary with the launch of its next-generation peptide microarray platform: cLIFT, short for combinatorial ...

The European direct-to-consumer genetic testing market is expected to reach USD 3.78 billion by 2035, growing from an ...

Biotinylated nucleotides have emerged as a powerful tool in molecular biology, enabling researchers to explore genetic materials with unprecedented precision and sensitivity. These modified ...

LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, ... provides specific array applications at a lower cost. Key Features: ...

Market Growth Driven by Increasing Consumer Awareness About Personalized Medicine, Growing Interest in Ancestry Research, Rising Prevalence of Chronic Diseases, and Technological Advancements ...

Emory University and Micron Biomedical announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...